JPWO2023053384A1 - - Google Patents
Info
- Publication number
- JPWO2023053384A1 JPWO2023053384A1 JP2023550943A JP2023550943A JPWO2023053384A1 JP WO2023053384 A1 JPWO2023053384 A1 JP WO2023053384A1 JP 2023550943 A JP2023550943 A JP 2023550943A JP 2023550943 A JP2023550943 A JP 2023550943A JP WO2023053384 A1 JPWO2023053384 A1 JP WO2023053384A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2021/036238 WO2023053384A1 (ja) | 2021-09-30 | 2021-09-30 | 脂肪肝および非アルコール性脂肪肝炎の治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023053384A1 true JPWO2023053384A1 (https=) | 2023-04-06 |
| JPWO2023053384A5 JPWO2023053384A5 (https=) | 2024-10-07 |
| JP7798300B2 JP7798300B2 (ja) | 2026-01-14 |
Family
ID=85781770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550943A Active JP7798300B2 (ja) | 2021-09-30 | 2021-09-30 | 脂肪肝および非アルコール性脂肪肝炎の治療薬 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240299496A1 (https=) |
| EP (1) | EP4410302A4 (https=) |
| JP (1) | JP7798300B2 (https=) |
| KR (1) | KR20240070640A (https=) |
| CN (1) | CN118317780A (https=) |
| AU (1) | AU2021466375A1 (https=) |
| CA (1) | CA3233234A1 (https=) |
| MX (1) | MX2024003974A (https=) |
| WO (2) | WO2023053384A1 (https=) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018186480A1 (ja) * | 2017-04-07 | 2018-10-11 | 株式会社ステムリム | 線維性疾患の治療薬 |
| US20200282017A1 (en) * | 2019-03-06 | 2020-09-10 | The Cleveland Clinic Foundation | Compositions and method for reducing virulence of microorganisms |
| JP2021508491A (ja) * | 2017-12-18 | 2021-03-11 | アルナイラム ファーマシューティカルズ， インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 高移動度グループボックス−１（ＨＭＧＢ１）ｉＲＮＡ組成物及びその使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3358011T (pt) | 2011-04-26 | 2020-04-23 | Univ Osaka | Péptido para induzir a regeneração de um tecido e a sua utilização |
-
2021
- 2021-09-30 AU AU2021466375A patent/AU2021466375A1/en active Pending
- 2021-09-30 CA CA3233234A patent/CA3233234A1/en active Pending
- 2021-09-30 WO PCT/JP2021/036238 patent/WO2023053384A1/ja not_active Ceased
- 2021-09-30 KR KR1020247014019A patent/KR20240070640A/ko active Pending
- 2021-09-30 JP JP2023550943A patent/JP7798300B2/ja active Active
-
2022
- 2022-09-30 MX MX2024003974A patent/MX2024003974A/es unknown
- 2022-09-30 EP EP22876529.3A patent/EP4410302A4/en active Pending
- 2022-09-30 WO PCT/JP2022/036662 patent/WO2023054666A1/ja not_active Ceased
- 2022-09-30 CN CN202280078804.6A patent/CN118317780A/zh active Pending
- 2022-09-30 US US18/697,330 patent/US20240299496A1/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018186480A1 (ja) * | 2017-04-07 | 2018-10-11 | 株式会社ステムリム | 線維性疾患の治療薬 |
| JP2021508491A (ja) * | 2017-12-18 | 2021-03-11 | アルナイラム ファーマシューティカルズ， インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 高移動度グループボックス−１（ＨＭＧＢ１）ｉＲＮＡ組成物及びその使用方法 |
| US20200282017A1 (en) * | 2019-03-06 | 2020-09-10 | The Cleveland Clinic Foundation | Compositions and method for reducing virulence of microorganisms |
Non-Patent Citations (6)
| Title |
|---|
| DATABASE REGISTRY [ONLINE], vol. Retrieved from STN, JPN7021004971, pages 1606186 - 88, ISSN: 0005744083 * |
| NOJIRI SHUNSUKE ET AL.: "Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice", INFLAMMATION AND REGENERATION, vol. 41, JPN6021045678, 2021, pages 28, ISSN: 0005744085 * |
| S-005151の慢性肝疾患患者を対象とした第２相試験, JPN6021045679, 7 January 2021 (2021-01-07), ISSN: 0005744084 * |
| 医薬品の一般的名称について, JPN6021045682, ISSN: 0005744082 * |
| 土屋淳紀: "HMGB1の部分ペプチドを用いた慢性肝疾患に対するセルフリー治療の開発", 肝臓, vol. Vol.62, Suppl.1, JPN6021045677, 20 April 2021 (2021-04-20), pages 69 - 2, ISSN: 0005744086 * |
| 日本初の人工ペプチド「レダセムチド（S-005151）」を用いた慢性肝疾患に対する線維化改善、再生促進を目指, JPN6021045684, 12 November 2020 (2020-11-12), ISSN: 0005744081 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240299496A1 (en) | 2024-09-12 |
| EP4410302A1 (en) | 2024-08-07 |
| EP4410302A4 (en) | 2025-07-23 |
| AU2021466375A1 (en) | 2024-04-11 |
| KR20240070640A (ko) | 2024-05-21 |
| CA3233234A1 (en) | 2023-04-06 |
| WO2023054666A1 (ja) | 2023-04-06 |
| CN118317780A (zh) | 2024-07-09 |
| WO2023053384A1 (ja) | 2023-04-06 |
| MX2024003974A (es) | 2024-07-09 |
| JP7798300B2 (ja) | 2026-01-14 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A801 Effective date: 20240327 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240405 |
|
| A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20240415 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240927 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240927 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20251202 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251217 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7798300 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |